These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5626768)

  • 1. Contact activation of Hageman factor and the interaction of Hageman factor and plasma thromboplastin antecedent.
    Haanen C; Morselt G; Schoenmakers J
    Thromb Diath Haemorrh; 1967 May; 17(3-4):307-20. PubMed ID: 5626768
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator.
    Forbes CD; Pensky J; Ratnoff OD
    J Lab Clin Med; 1970 Nov; 76(5):809-15. PubMed ID: 5477337
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the product of the reaction between activated Hageman factor (factor XII) and plasma thromboplastin antecedent (factor XI).
    Ratnoff OD
    J Lab Clin Med; 1972 Nov; 80(5):704-10. PubMed ID: 4673237
    [No Abstract]   [Full Text] [Related]  

  • 4. The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments.
    Goldsmith GH; Saito H; Ratnoff OS
    J Clin Invest; 1978 Jul; 62(1):54-60. PubMed ID: 659637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the activation of Hageman factor (factor XII) by extracts of Schistosoma mansoni.
    Foster CB; Flanigan TP; DeStigter KK; Blanton R; Dumenco LL; Gallagher C; Ratnoff OD
    J Lab Clin Med; 1992 Nov; 120(5):735-9. PubMed ID: 1431502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inflammatory process in acute gouty arthritis. II. The presence of Hageman factor and plasma thromboplastin antecedent in synovial fluid.
    Kellermeyer RW; Breckenridge RT
    J Lab Clin Med; 1966 Mar; 67(3):455-60. PubMed ID: 5910152
    [No Abstract]   [Full Text] [Related]  

  • 8. Contact product in experimental intravascular activation of the clotting system.
    Altman R; Rouvier J; Daldin J
    Rev Bras Pesqui Med Biol; 1973; 6(5):223-8. PubMed ID: 4774622
    [No Abstract]   [Full Text] [Related]  

  • 9. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
    Weiss AS; Gallin JI; Kaplan AP
    J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood coagulation. Role of Hageman protein (F-XII) and autoprothrombin II (F-IX?) in the activation of autoprothrombin 3 (F-X).
    Seegers WH; Grammens GL; McCoy LE
    Thromb Diath Haemorrh; 1970 Dec; 24(3):345-51. PubMed ID: 5533980
    [No Abstract]   [Full Text] [Related]  

  • 11. Activation of Hageman factor by collagen.
    Wilner GD; Nossel HL; LeRoy EC
    J Clin Invest; 1968 Dec; 47(12):2608-15. PubMed ID: 4302176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent.
    RATNOFF OD; DAVIE EW; MALLETT DL
    J Clin Invest; 1961 May; 40(5):803-19. PubMed ID: 13739760
    [No Abstract]   [Full Text] [Related]  

  • 13. Activation of human factor XI (plasma thromboplastin antecedent) by factor XIIa (activated Hageman factor).
    Kurachi K; Davie EW
    Biochemistry; 1977 Dec; 16(26):5831-9. PubMed ID: 588558
    [No Abstract]   [Full Text] [Related]  

  • 14. Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells.
    Wiggins RC; Loskutoff DJ; Cochrane CG; Griffin JH; Edgington TS
    J Clin Invest; 1980 Jan; 65(1):197-206. PubMed ID: 6444222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Hageman factor, plasma thromboplastin antecedent, thrombin and other clotting factors by phenylglyoxal hydrate (38500).
    Radnoff OD; Saito H
    Proc Soc Exp Biol Med; 1975 Jan; 148(1):177-82. PubMed ID: 236567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory action of amyloid precursor protein against human Hageman factor (factor XII).
    Niwano H; Embury PB; Greenberg BD; Ratnoff OD
    J Lab Clin Med; 1995 Feb; 125(2):251-6. PubMed ID: 7844473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Hageman factor activation.
    Nossel HL; Rubin H; Drillings M; Hsieh R
    J Clin Invest; 1968 May; 47(5):1172-80. PubMed ID: 5645860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors.
    Ogston D; Ogston CM; Ratnoff OD; Forbes CD
    J Clin Invest; 1969 Oct; 48(10):1786-801. PubMed ID: 4241814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Realease of anticoagulants and fibrinolysis activator by a nervous mechanism following renal perfusion with surface factor and thrombin.
    Neri Serneri GG; Masotti G; Paoletti P; Silvestrini E; Donnini L
    Rass Neurol Veg; 1968; 22(5):445-68. PubMed ID: 5714088
    [No Abstract]   [Full Text] [Related]  

  • 20. The contact phase of coagulation in the presence of heparin.
    BLOOM AL
    J Clin Pathol; 1962 Nov; 15(6):508-10. PubMed ID: 13971779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.